EC Number | Application | Comment | Organism |
---|---|---|---|
2.1.1.1 | pharmacology | biomarkers for cardiovascular risk factors | Homo sapiens |
EC Number | Organism | UniProt | Comment | Textmining |
---|---|---|---|---|
2.1.1.1 | Homo sapiens | P40261 | - |
- |
EC Number | Source Tissue | Comment | Organism | Textmining |
---|---|---|---|---|
2.1.1.1 | blood plasma | - |
Homo sapiens | - |
EC Number | Specific Activity Minimum [µmol/min/mg] | Specific Activity Maximum [µmol/min/mg] | Comment | Organism |
---|---|---|---|---|
2.1.1.1 | additional information | - |
association between A/G single nucleotide polymorphism of NNMT gene and total homocysteine concentration in plasma of Japanese man analyzed, genotyping by PCR followed by melting curve analysis, NNMT genotype not determined as a strong determinant of total homocysteine concentration in plasma, modifying effect on plasma homocysteine concentration not excluded | Homo sapiens |
EC Number | Substrates | Comment Substrates | Organism | Products | Comment (Products) | Rev. | Reac. |
---|---|---|---|---|---|---|---|
2.1.1.1 | S-adenosyl-L-methionine + nicotinamide | NNMT gene polymorphism as potential marker for cardiovascular risk factors | Homo sapiens | S-adenosyl-L-homocysteine + 1-methylnicotinamide | - |
? |
EC Number | Synonyms | Comment | Organism |
---|---|---|---|
2.1.1.1 | NNMT | - |
Homo sapiens |